5.2: Reduced Sublingual Endothelial Glycocalyx in Type 1 Diabetics with Diabetic Nephropathy

被引：0
|
作者：
Signe Abitz Winther
机构：
[1] Steno Diabetes Center Copenhagen and Novo Nordisk A/S,
来源：
Artery Research | 2017年 / 20卷 / 1期
关键词：
D O I：
10.1016/j.artres.2017.10.048
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 59
相关论文
共 50 条
  • [1] Reduced sublingual endothelial glycocalyx in type 1 diabetic patients with diabetic nephropathy
    Winther, S. A.
    Frimodt-Moller, M.
    Zobel, E. H.
    Hansen, T. W.
    Rossing, P.
    [J]. DIABETOLOGIA, 2017, 60 : S499 - S500
  • [2] Endothelial glycocalyx restoration by growth factors in diabetic nephropathy
    Desideri, Sara
    Onions, Karen L.
    Baker, Sian L.
    Gamez, Monica
    Hussien, Hesham El Hegni E.
    Russell, Amy
    Satchell, Simon C.
    Foster, Rebecca R.
    [J]. BIORHEOLOGY, 2019, 56 (2-3) : 163 - 179
  • [3] Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy
    Toyoda, Masao
    Najafian, Behzad
    Kim, Youngki
    Caramori, M. Luiza
    Mauer, Michael
    [J]. DIABETES, 2007, 56 (08) : 2155 - 2160
  • [4] The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy
    Korakas, Emmanouil
    Ikonomidis, Ignatios
    Markakis, Konstantinos
    Raptis, Athanasios
    Dimitriadis, George
    Lambadiari, Vaia
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (06) : 619 - 631
  • [5] Endothelial function in offspring of Type 1 diabetic patients with and without diabetic nephropathy
    McAllister, AS
    Atkinson, AB
    Johnston, GD
    McCance, DR
    [J]. DIABETIC MEDICINE, 1999, 16 (04) : 298 - 303
  • [6] Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
    Boels, Margien G. S.
    Avramut, M. Cristina
    Koudijs, Angela
    Dane, Martijn J. C.
    Lee, Dae Hyun
    van der Vlag, Johan
    Koster, Abraham J.
    van Zonneveld, Anton Jan
    van Faassen, Ernst
    Groene, Hermann-Josef
    van den Berg, Bernard M.
    Rabelink, Ton J.
    [J]. DIABETES, 2016, 65 (08) : 2429 - 2439
  • [7] Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
    Yilmaz, Mahmut Ilker
    Saglam, Mutlu
    Qureshi, Abdul Rashid
    Carrero, Juan Jesus
    Caglar, Kayser
    Eyileten, Tayfun
    Sonmez, Alper
    Cakir, Erdinc
    Oguz, Yusuf
    Vural, Abdulgaffar
    Yenicesu, Mujdat
    Stenvinkel, Peter
    Lindholm, Bengt
    Axelsson, Jonas
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (05) : 1621 - 1627
  • [8] The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics
    Vionnet, N
    Marre, M
    Groop, PH
    Tarnow, L
    Lemainque, A
    Hadjadj, S
    Parving, HH
    Forsblom, C
    Tregouet, D
    Farrall, M
    Cambien, F
    Lathrop, M
    [J]. DIABETES & METABOLISM, 2006, 32 : S50 - S51
  • [9] Prevalence and predictive factors of diabetic nephropathy in type 2 diabetics
    Kacem, A.
    Ben Ahmed, I.
    Berriche, O.
    Jamoussi, H.
    Ben Ammar, I.
    Mnif, S.
    Blouza, S.
    [J]. DIABETES & METABOLISM, 2008, 34 : A83 - A83
  • [10] When to begin screening for diabetic nephropathy among type 1 diabetics in our population?
    Yadav, Sangeeta
    Samanta, Debopam
    Mallika, V.
    [J]. HORMONE RESEARCH, 2009, 72 : 476 - 476
12345